期刊文献+

Survivin、RAGE和HMGB1在乳腺癌中表达及其临床意义 被引量:2

Expression of Survivin, RAGE and HMGB1 gene in human breast cancer and its clinical significance
原文传递
导出
摘要 目的探讨乳腺癌组织中Survivin、RAGE和HMGBl基因表达及其临床意义。方法对50例早期(I+Ⅱ期)、50例晚期(Ⅲ+Ⅳ期)乳腺癌及100例对照组蜡块标本,运用Real—timePCR和荧光原位杂交技术(FISH)技术检测Survivin、RAGE和HMGBI基因表达。并分析各基因表达与乳腺癌组织的分化程度、浸润深度、淋巴结转移、TNM分期之间的关系。结果Survivin、RAGE和HMGBl基因表达荧光实时定量PCR法上调分别为62%、73%、79%,FISH法基因扩增阳性分别为78%、69%、72%。乳腺癌TNM分期、淋巴结转移与基因高表达有密切关系,Survivin基因表达与RAGE、HMGBl表达呈正相关。结论Survivin、RAGE和HMGBl基因表达对乳腺癌早期诊断和预后分析有重要指导意义。 Objective To investigate the expression of Survivin, receptor for advanced glycation end- product(RAGE) and high mobility group protein B1 (HMGB1) gene in human breast cancer and their clinical significance. Methods The expression of Survivin, RAGE and HMGB1 gene was detected by Real-time PCR technology and fluorescence in situ hybridization (FISH) technology in the following tissue samples: 50 early breast cancers, 50 advanced breast cancers, and the corresponding adjacent normal mammary tissues. The rela- tionship of their expression and several factors such as differentiation degree, invasion, lymph node metastasis and TNM stage of cancer was explored. Results The positive expression rate of Survivin, RAGE and HMGB1 gene was 62%, 73% and 79% detected by Real-time PCR technology, 78% , 69% and 72% detected by FISH tech- nology in breast cancer tissues. The overexpression of these genes was positively correlated with TNM stage and lymph node metastasis. The expression of Survivin gene was positively correlated with the expression of RAGE and HMGB1. Conclusion Overexpression of Survivin, RAGE and HMGB1 gene is of great significance in early di- agnosis and prognosis of human breast cancer.
出处 《中华内分泌外科杂志》 CAS 2012年第6期409-412,共4页 Chinese Journal of Endocrine Surgery
基金 连云港市卫生局基金项目(1015)
关键词 乳腺癌 SURVIVIN RAGE HMGB1 淋巴结转移 Real-time PCR 荧光原位杂交技术(FISH) Breast cancer Survivin RAGE HMGB 1 Lymph node metastasis Real-time PCR FISH
  • 相关文献

参考文献16

  • 1鲁凯,姚壮凯,刘燕文,叶红玲,吕三云.乳腺癌中Survivin基因的研究及其临床意义[J].中华内分泌外科杂志,2012,6(5):323-326. 被引量:4
  • 2周振宇,谷元廷.乳腺癌组织中Survivin基因的表达及临床意义[J].中国现代药物应用,2010,4(18):1-2. 被引量:6
  • 3鲁凯,姚壮凯,刘燕文,赵成,刘永平.胃癌组织中nm23-H1、c—Met和survivin蛋白表达及临床意义[J].中华内分泌外科杂志,2009,3(4):226-229. 被引量:2
  • 4Cieslik K, Zembowicz A, Tang JL, et al. Transcriptional regula- tion of endothelial nitric-oxide synthase by lysophosphatidylcholine [J]. J Biol Chem,1998,273(24) :14885-14890.
  • 5张真,张小涛,于兰,马学真,韩淑红.乳腺癌CD44v6和Survivin 的表达与临床预后的相关性研究[J].中国肿瘤临床,2011,38(14):835-838. 被引量:14
  • 6Okada E, Murai Y, Matsui K, et al. Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients [ J ]. Cancer Lett, 2001,163 ( 1 ) : 109 -116.
  • 7Kuniyasu H, Oue N, Wakikawa A, et al. Expression of receptors for advanced glycation end-products ( RAGE ) is closely associated with the invasive and metastatic activity of gastric cancer [ J ]. J Pathol,2002,196(2) : 163-170.
  • 8Ishiguro H, Nakaigawa N, Miyoshi Y, et al. Receptor for ad- vanced glycation end products(RAGE) and its ligand, amphotefin are overexpressed and associated with prostate cancer development [J]. Prostate, 2005, 64(1):92-100.
  • 9Kuniyasu H, Chihara Y, Takahashi T. Co-expression of receptor for advanced gIycation end products and the ligand amphoterin as- sociates closely with metastasis of colorectal cancer [ J ]. Oncol Rep,2003, 10(2) : 445-448.
  • 10Takada M, Hirata K, Ajiki T, et al. Expression of receptor for ad- vanced glycation end products(RAGE) and MMp-9 in human pan- creation cancer cells[ J]. Hepatogastroenterology,2004, 51 ( 58 ) : 928 -930.

二级参考文献30

  • 1李继霞,周克元,梁统,张月飞.利用siRNA阻抑survivin基因表达诱导乳腺癌细胞系MCF-7细胞凋亡的研究(英文)[J].癌症,2005,24(3):268-272. 被引量:16
  • 2毛杰,海健,舒衡平,邬玉辉,欧慧英,罗沙阳,王守满.乳腺癌组织中Survivin和nm23蛋白的表达及其与腋淋巴结转移的关系[J].中南大学学报(医学版),2005,30(3):312-314. 被引量:5
  • 3Singh M, Bleile MJ, Shroyer AL, et al. Analysis of survivin expres- sion in a spectrum of benign to malignant lesions of the breast[J]. ADD1 Immunohistochem Mol Morohol,2004. 12(4): 296-304.
  • 4A1-Joudi FS, Iskandar ZA. Autoantibodies to survivin in the sera of patients with infiltrating ductal carcinoma of the breast[J]. Med J Malaysia, 2006, 61 (3): 302-306.
  • 5Pennati M, Folini M, Zaffaroni N. Targeting survivin in cancer therapy: fulfilled promises and open questions[J]. Carcinogenesis, 2007, 28(6): 1133-1139.
  • 6宁连胜,方志沂,主泽.现代乳腺疾病治疗学[M].第二版.北京:人民卫生出版社,2007:59-61.
  • 7Kohlberger PD, Breitenecker F, Kaider A, et al. Modified true-color computer-assisted image analysis versus subjective scoring of estrogen receptor expression in breast cancer: a comparison[J]. Anticancer Res, 1999, 19(3B): 2189-2193.
  • 8Afify A, Purnell P, Nguyen L. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion[J]. Exp Mol Pathol, 2009, 86(2): 95-100.
  • 9Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecules to signalling regulators[J]. Nat Rev Mol Cell BioI, 2003, 4(1): 33-45.
  • 10Kaufmann M, Heider KH, Sinn HP, et al. CD44 variant exon epitopes in primary breast cancer and length of survival[J]. Lancet, 1995, 345 (8950): 615-619.

共引文献20

同被引文献20

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部